Correlation Between Cannabis Strategic and Bionoid Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cannabis Strategic and Bionoid Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannabis Strategic and Bionoid Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannabis Strategic Ventures and Bionoid Pharma, you can compare the effects of market volatilities on Cannabis Strategic and Bionoid Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannabis Strategic with a short position of Bionoid Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannabis Strategic and Bionoid Pharma.

Diversification Opportunities for Cannabis Strategic and Bionoid Pharma

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Cannabis and Bionoid is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Cannabis Strategic Ventures and Bionoid Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionoid Pharma and Cannabis Strategic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannabis Strategic Ventures are associated (or correlated) with Bionoid Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionoid Pharma has no effect on the direction of Cannabis Strategic i.e., Cannabis Strategic and Bionoid Pharma go up and down completely randomly.

Pair Corralation between Cannabis Strategic and Bionoid Pharma

Given the investment horizon of 90 days Cannabis Strategic Ventures is expected to generate 5.74 times more return on investment than Bionoid Pharma. However, Cannabis Strategic is 5.74 times more volatile than Bionoid Pharma. It trades about 0.27 of its potential returns per unit of risk. Bionoid Pharma is currently generating about 0.06 per unit of risk. If you would invest  0.70  in Cannabis Strategic Ventures on August 26, 2024 and sell it today you would lose (0.69) from holding Cannabis Strategic Ventures or give up 98.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cannabis Strategic Ventures  vs.  Bionoid Pharma

 Performance 
       Timeline  
Cannabis Strategic 

Risk-Adjusted Performance

24 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Cannabis Strategic Ventures are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating technical and fundamental indicators, Cannabis Strategic unveiled solid returns over the last few months and may actually be approaching a breakup point.
Bionoid Pharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Cannabis Strategic and Bionoid Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cannabis Strategic and Bionoid Pharma

The main advantage of trading using opposite Cannabis Strategic and Bionoid Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannabis Strategic position performs unexpectedly, Bionoid Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will offset losses from the drop in Bionoid Pharma's long position.
The idea behind Cannabis Strategic Ventures and Bionoid Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments